Следене
Nicholas P Tatonetti
Nicholas P Tatonetti
Vice Chair of Computational Biomedicine; Associate Director of Cancer Center, Cedars-Sinai
Потвърден имейл адрес: cshs.org - Начална страница
Заглавие
Позовавания
Позовавания
Година
Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
SJ Dixon, DN Patel, M Welsch, R Skouta, ED Lee, M Hayano, AG Thomas, ...
elife 3, e02523, 2014
11632014
Data-driven prediction of drug effects and interactions
NP Tatonetti, PP Ye, R Daneshjou, RB Altman
Science translational medicine 4 (125), 125ra31-125ra31, 2012
6992012
Associations between blood type and COVID-19 infection, intubation, and death
M Zietz, J Zucker, NP Tatonetti
Nature communications 11 (1), 5761, 2020
4812020
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study
MA Perera, LH Cavallari, NA Limdi, ER Gamazon, A Konkashbaev, ...
The Lancet 382 (9894), 790-796, 2013
2732013
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
V Ramlall, PM Thangaraj, C Meydan, J Foox, D Butler, J Kim, B May, ...
Nature medicine 26 (10), 1609-1615, 2020
2512020
Web-scale pharmacovigilance: listening to signals from the crowd
RW White, NP Tatonetti, NH Shah, RB Altman, E Horvitz
Journal of the American Medical Informatics Association 20 (3), 404-408, 2013
2432013
Detecting drug interactions from adverse‐event reports: interaction between paroxetine and pravastatin increases blood glucose levels
NP Tatonetti, JC Denny, SN Murphy, GH Fernald, G Krishnan, V Castro, ...
Clinical Pharmacology & Therapeutics 90 (1), 133-142, 2011
2312011
A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports
NP Tatonetti, GH Fernald, RB Altman
Journal of the American Medical Informatics Association 19 (1), 79-85, 2011
2102011
Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions
D Butler, C Mozsary, C Meydan, J Foox, J Rosiene, A Shaiber, D Danko, ...
Nature communications 12 (1), 1660, 2021
187*2021
Similarity-based modeling in large-scale prediction of drug-drug interactions
S Vilar, E Uriarte, L Santana, T Lorberbaum, G Hripcsak, C Friedman, ...
Nature protocols 9 (9), 2147-2163, 2014
1772014
Predictive modeling of hospital readmission rates using electronic medical record-wide machine learning: a case-study using Mount Sinai heart failure cohort
K Shameer, KW Johnson, A Yahi, R Miotto, LI Li, D Ricks, J Jebakaran, ...
Pacific Symposium on Biocomputing 2017, 276-287, 2017
1552017
High-throughput methods for combinatorial drug discovery
X Sun, S Vilar, NP Tatonetti
Science translational medicine 5 (205), 205rv1-205rv1, 2013
1542013
Toward a complete dataset of drug–drug interaction information from publicly available sources
S Ayvaz, J Horn, O Hassanzadeh, Q Zhu, J Stan, NP Tatonetti, S Vilar, ...
Journal of biomedical informatics 55, 206-217, 2015
1442015
A curated and standardized adverse drug event resource to accelerate drug safety research
JM Banda, L Evans, RS Vanguri, NP Tatonetti, PB Ryan, NH Shah
Scientific data 3 (1), 1-11, 2016
1402016
Artificial intelligence for drug toxicity and safety
AO Basile, A Yahi, NP Tatonetti
Trends in pharmacological sciences 40 (9), 624-635, 2019
1352019
Birth month affects lifetime disease risk: a phenome-wide method
MR Boland, Z Shahn, D Madigan, G Hripcsak, NP Tatonetti
Journal of the American Medical Informatics Association 22 (5), 1042-1053, 2015
1302015
The Weber effect and the United States Food and Drug Administration’s Adverse Event Reporting System (FAERS): analysis of sixty-two drugs approved from 2006 to 2010
KB Hoffman, M Dimbil, CB Erdman, NP Tatonetti, BM Overstreet
Drug safety 37, 283-294, 2014
1262014
Detection of drug-drug interactions by modeling interaction profile fingerprints
S Vilar, E Uriarte, L Santana, NP Tatonetti, C Friedman
PloS one 8 (3), e58321, 2013
1102013
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies
C Deng, MR Lipstein, L Scotto, XO Jirau Serrano, MA Mangone, S Li, ...
Blood, The Journal of the American Society of Hematology 129 (1), 88-99, 2017
1052017
Molecular nephrology: types of acute tubular injury
B Desanti De Oliveira, K Xu, TH Shen, M Callahan, K Kiryluk, VD D’Agati, ...
Nature Reviews Nephrology 15 (10), 599-612, 2019
942019
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20